News and Events, Recent News

BriaCell Closes Oversubscribed Non-Brokered Private Placement

BERKELEY, CALIFORNIA and VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug. 19, 2016) – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX VENTURE:BCT)(OTCQB:BCTXF) is pleased to announce it has completed its previously announced non-brokered private placement financing (the “Offering”) of units (the “Units”) for aggregate gross proceeds to the Company in the amount of $1,700,000. Under the Offering, […]

News and Events, Recent News

BriaCell Appoints the Lead Principal Investigator and First Clinical Site for its Upcoming Phase I/IIa Clinical Trial in Advanced Breast Cancer

– Dr. Jarrod P. Holmes, a prominent breast cancer vaccine expert to lead the study out of St. Joseph Health-Sonoma County Berkeley, CA and Vancouver, BC – August 17, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSXV: BCT) (OTCQB: BCTXF) is pleased to announce that Dr. Jarrod P. Holmes, a Board Certified Oncologist […]

News and Events, Recent News

BriaCell Announces Non-Brokered Private Placement

BriaCell Therapeutics Corp. (OTCQB:BCTXF)(TSX VENTURE:BCT) (“BriaCell”, the “Company”, or “BCT”) announced today that it intends to complete a non-brokered private placement (the “Offering”) of units of the Company (the “Units”) at a price of $0.20 per Unit for aggregate gross proceeds of up to $1,500,000. Under the Offering, each Unit shall consist of one common […]